GIMB Gimv NV
Gimv NV is a private equity and venture capital firm specializing in direct and fund of funds investments. For direct investments, the firm specializes in buyouts, growth capital, pre-revenue, middle market, debt, shareholder loans, seed, startups, early to mid-stage, mezzanine, late venture, emerging growth, public to private transactions, small and medium sized enterprises, later stage, mature, replacement capital, bridge financing, and recapitalization. Within fund of funds, it seeks to invest in venture capital and private equity funds. It seeks to invest in high performance growth companies that respond to that can speed up their internal growth through acquisitions. The firm typically invests in consumer, connected consumer, R&D driven companies that positively impact human health, environment, automation, health and care, demographics, financial services, consumer digital lending, telecommunication services, marketing services, interactive home entertainment, smart industries, and sustainable cities. Within health and care platform, the firm seeks to invest in companies that can grow either organically or through a buy and build strategy. Within consumer, it focuses on consumer goods, food, healthy food, prepared and preserved food, personal luxury, home & deco, homebuilding, household appliances, housewares and specialties, travel and leisure, education, digitalization and digital economy sectors. Within health and care sector, it focuses on life sciences, medtech, and health and care services, veterinary drugs, generic pharmaceuticals, vaccines and diagnostic tests, medical devices and consumables sectors. Within smart industries, it focuses on aerospace, energy transition, B2B services, advanced engineering and software sectors. Within sustainable cities, it focuses on infrastructure installation, consumer , energy, recycling and recovery, Infrastructure, transport and logistics services, water purification, e-commerce, alternative energy resources and energy efficient infrastructure. It invests in building; materials including chemicals, fertilizers and agricultural chemicals, mobility and operations, agricultural services, electronics and heavy electrical equipment. It mainly focuses on the DACH region that is Austria, Germany and Switzerland; Kazakhstan, Benelux, France, Italy, Luxembourg, Netherlands, United Kingdom, Russia, Czech Republic, and Slovakia and invests in small and medium sized businesses primarily with headquarters in the Benelux, France, and Germany. It typically makes investments between 5 million ($5.67 million) to 150 million ($170.22 million) in consumer, health care, smart industries and sustainable client sector. It may take a majority or a minority stake in its portfolio companies. Gimv NV was founded on February 25, 1980 and is based in Antwerp, Belgium with additional offices in Paris, France; Hague, The Netherlands; Frankfurt am Main, Germany; London, United Kingdom; Prague, Czech Republic; Warsaw, Poland; and Munich, Germany.…
Industry Peers
Asset ManagementKey Statistics
About Gimv (EBR: GIMB)
›
Gimv (EBR: GIMB) is listed on Euronext Brussels, where its shares trade in EUR. It belongs to the Asset Management industry, part of the Financial Services sector, and reports about 95 employees.
The shares were at 48.00 EUR on 20 November 2026, up 10.0% over 52 weeks. Its 52-week range is 42.35 EUR to 50.80 EUR: the price is 5.5% below the high and 13.3% above the low.
At a market capitalisation of 1.78B EUR, it trades at 8.1 times trailing earnings and 42.1 times forward earnings. The median trailing P/E of its 18 largest Asset Management peers is 14.8, a discount of 46% for GIMB. It pays a dividend yielding 4.01% (it pays out 44% of its earnings), against a median of 1.81% among the dividend payers in that peer group.
Gimv reports return on equity of 11.5%, an operating margin of 79.6% and revenue up 65.2% year over year.
Its debt exceeds its cash by 237.15M EUR, a debt-to-equity ratio of 0.19. Its Piotroski F-score is 2 out of 9, a weak reading of its financial health. 4 analysts cover the stock; their mean price target of 51.50 EUR is 7.3% above the current price. The next earnings report is expected on 18 February 2027.